To identify additional kinases that are regulated during the development of resistance against the AKT/mTOR inhibitor treatment, we subjected protein lysates from this tumor tissue (T3) and from the tumor tissue of an untreated control mouse (C1) to serine/threonine and tyrosine kinase profiling using PamGene micro arrays. This evidence concerns the gene MTOR and neoplasm.